Skip to content

A new radioactive agent developed at Stanford can identify whether a widely used lung cancer drug is likely to be effective.

A new radioactive agent developed at Stanford can identify whether a widely used lung cancer drug is likely to be effective.

Published on

Stanford's Mary Leonard has devoted her research career to understanding how chronic diseases weaken children's bones, and what we can do about it.

Stanford's Mary Leonard has devoted her research career to understanding how chronic diseases weaken children's bones, and what we can do about it.

Published on